ID: ALA5205025

Max Phase: Preclinical

Molecular Formula: C18H22N2O4S

Molecular Weight: 362.45

Associated Items:

Representations

Canonical SMILES:  CCOc1ccccc1NC(=O)c1cc(C)ccc1NS(=O)(=O)CC

Standard InChI:  InChI=1S/C18H22N2O4S/c1-4-24-17-9-7-6-8-16(17)19-18(21)14-12-13(3)10-11-15(14)20-25(22,23)5-2/h6-12,20H,4-5H2,1-3H3,(H,19,21)

Standard InChI Key:  MBLVWVPFNLIBCI-UHFFFAOYSA-N

Associated Targets(Human)

Mas-related G-protein coupled receptor member X1 365 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 362.45Molecular Weight (Monoisotopic): 362.1300AlogP: 3.41#Rotatable Bonds: 7
Polar Surface Area: 84.50Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.96CX Basic pKa: CX LogP: 2.66CX LogD: 2.57
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.79Np Likeness Score: -2.06

References

1. Sharma S, Peng Q, Vadukoot AK, Aretz CD, Jensen AA, Wallick AI, Dong X, Hopkins CR..  (2022)  Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1.,  13  (5.0): [PMID:35586421] [10.1021/acsmedchemlett.2c00100]

Source